Rapport
EMCDDA-Europol Joint Report on a new psychoactive substance: 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) : In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances
Auteur(s) :
OEDT = EMCDDA (Observatoire européen des drogues et des dépendances = European monitoring centre for drugs and drug addiction) ;
Europol
Année
2018
Page(s) :
16 p.
Langue(s) :
Anglais
Éditeur(s) :
Lisbon : OEDT / EMCDDA
;
The Hague : Europol
Collection :
Joint reports
ISBN :
978-92-9497-256-9
Domaine :
Autres substances / Other substances
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Organismes
OEDT
Thésaurus mots-clés
DROGUES DE SYNTHESE
;
CHIMIE
;
PHENOMENE EMERGENT
;
CONTROLE DES STUPEFIANTS
;
ANALYSE CHIMIQUE
;
TOXICOLOGIE
;
SAISIE
;
PRODUCTION
;
INTOXICATION
;
FACTEUR DE RISQUE
;
PHARMACOLOGIE
;
FENTANYL
;
TRAFIC
;
EFFET SECONDAIRE
Thésaurus géographique
EUROPE
Résumé :
In September 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl), through a joint assessment. The two organisations launched a data collection on this substance for the preparation of a Joint Report as stipulated by Article 5.1 of the Council Decision. The Joint Report was submitted to the Council, the Commission and the European Medicines Agency on 19 December 2017.
Historique